Deborah M. Kurrasch-Orbaugh, Ph.D.
Affiliations: | Purdue University, West Lafayette, IN, United States |
Area:
Dopamine and Serotonin AgonistsGoogle:
"Deborah Kurrasch-Orbaugh"Mean distance: 18.16 (cluster 11)
Parents
Sign in to add mentor| David E. Nichols | grad student | 2002 | Purdue | |
| (Elucidation of the serotonin 5-HT(2A) receptor-coupled phospholipase A(2) signaling pathway.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Laban U, Kurrasch-Orbaugh D, Marona-Lewicka D, et al. (2010) ChemInform Abstract: A Novel Fluorinated Tryptamine with Highly Potent Serotonin 5-HT1A Receptor Agonist Properties. Cheminform. 32: no-no |
| McLean TH, Chambers JJ, Parrish JC, et al. (2006) C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor. Journal of Medicinal Chemistry. 49: 4269-74 |
| Kurrasch-Orbaugh DM, Parrish JC, Watts VJ, et al. (2003) A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases. Journal of Neurochemistry. 86: 980-91 |
| Chambers JJ, Parrish JC, Jensen NH, et al. (2003) Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands. Journal of Medicinal Chemistry. 46: 3526-35 |
| Kurrasch-Orbaugh DM, Watts VJ, Barker EL, et al. (2003) Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves. The Journal of Pharmacology and Experimental Therapeutics. 304: 229-37 |
| Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, et al. (2002) Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats. Psychopharmacology. 164: 93-107 |
| Nichols DE, Frescas S, Marona-Lewicka D, et al. (2002) Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD). Journal of Medicinal Chemistry. 45: 4344-9 |
| Whiteside MS, Kurrasch-Orbaugh D, Marona-Lewicka D, et al. (2002) Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes. Bioorganic & Medicinal Chemistry. 10: 3301-6 |
| Chambers JJ, Kurrasch-Orbaugh DM, Nichols DE. (2002) Translocation of the 5-alkoxy substituent of 2,5-dialkoxyarylalkylamines to the 6-position: effects on 5-HT(2A/2C) receptor affinity. Bioorganic & Medicinal Chemistry Letters. 12: 1997-9 |
| Chambers JJ, Kurrasch-Orbaugh DM, Parker MA, et al. (2001) Enantiospecific synthesis and pharmacological evaluation of a series of super-potent, conformationally restricted 5-HT(2A/2C) receptor agonists. Journal of Medicinal Chemistry. 44: 1003-10 |